Novavax strikes $1.2 billion deal with Sanofi in major turnaround

Share on linkedin Vials of Novavax COVID-19 vaccine. Photo: Matthias Bein/picture alliance via Getty Imagesand entering into a licensing agreement worth as much as $1.2 billion that includes selling a combination COVID-flu shot.

Sanofi also is taking an approximately 5% equity stake in Novavax and will start booking sales of Novavax's COVID-19 vaccine next year.What they're saying: "With flu and COVID-19 hospital admission rates now closely mirroring each other, we have an opportunity to develop non-mRNA flu-COVID-19 combination vaccines offering patients both enhanced convenience and protection against two serious respiratory viruses," said Jean-Francois Toussaint, Sanofi's global heath of vaccines R&D.Its vaccine uses a protein from the target virus combined with what's called an adjuvant to enhance the body's immune response.

The approach makes Novavax's product easier to store than Moderna or Pfizer-BioNTech's vaccines, and an option for people who couldn't get or didn't want an mRNA vaccine.ran into early production problems and struggled to meet FDA standards, falling behind Moderna and Pfizer-BioNTech.in the development of a combination COVID-flu product to eliminate the need for multiple shots during respiratory virus season.

Source: News Formal (newsformal.com)

Pharmaceutical Companies Big Pharma Pharmaceutical Industry COVID-19 Vaccines COVID-19

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop combination shotsThe deal will allow Novavax to lift its 'going concern' warning, which it first issued in 2023 due to having 'substantial doubt' about its ability to survive.
Source: CNBC - 🏆 12. / 72 Read more »

Novavax stock explodes 75% on Sanofi partnershipNovavax stock explodes 75% on Sanofi partnership
Source: Investingcom - 🏆 450. / 53 Read more »

French, US drug firms team up for Covid-flu shotFrench pharmaceutical giant Sanofi and struggling US rival Novavax announced Friday an alliance to sell a Covid vaccine and develop another that combines with a flu shot.
Source: KJNBNews - 🏆 526. / 51 Read more »

Stocks making the biggest moves premarket: Yelp, Sweetgreen, Novavax, Akamai Technologies and moreThese are the stocks posting the largest moves in premarket trading.
Source: CNBC - 🏆 12. / 72 Read more »

Novavax, Nvidia, Sweetgreen rise premarket; Moderna, Yelp fallNovavax, Nvidia, Sweetgreen rise premarket; Moderna, Yelp fall
Source: Investingcom - 🏆 450. / 53 Read more »

Sanofi Q1 profit slips on generic competition, forex effectsSanofi Q1 profit slips on generic competition, forex effects
Source: Investingcom - 🏆 450. / 53 Read more »